Discovery of drug response in IDH mutant gliomas with a potential to treat astrocytomas and oligodendrogliomas. cancerres.aacrjournals.org/c… Very pleased that this has just been published in CANCER RESEARCH. Will be in Pubmed soon.

Mutant IDH sensitizes gliomas to endoplasmic reticulum stress and triggers apoptosis by MicroRNA183-mediated inhibition of Semaphorin 3E cancerres.aacrjournals.org/c…

Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre app.peer.us/papers/public/5c…

I think it may be more common than previously thought. Just need to observe carefully and connect the facts.

Indeed, important and groundbreaking finding that change the view on transmissible proteopathies

nature.com/articles/s41388-0… Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades

rdcu.be/NGwB: GPR 158 and miR-449 as new brain tumour malignancy bio-markers and possible therapeutic targets

It was an interesting and engaging event. Well done! xitter.cf/mtvc2/status/988698399…

nature.com/articles/s41388-0… Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades: Possible new therapeutic target and biomarker.

Next step: to update with new subclasses. xitter.cf/M_Preusser/status/9742…

We are not changing that much actually. Of 400 tumours in our lab, we changed diagnosis on 20%. And these 400 are a 10% selection already. So, no worries we'll stick with WHO 2016 for most tumours for a while xitter.cf/DrPaolini/status/97504…

and we thought: let's look into this in more detail. link.springer.com/article/10…

then we saw this nhs.uk/news/neurology/no-evi…

that was two years ago.

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy nature.com/articles/nature15…